Charles J. Sherr

Last updated
Charles J. Sherr
Born1944 (age 7778) [1]
Alma mater
Spouse(s)Martine Roussel
Scientific career
Institutions

Charles J. Sherr (born 1944) is the chair of the Tumor Cell Biology Department at St. Jude Children's Research Hospital. He studies tumor suppressor genes and cell division. [2] [3]

Sherr received his AB from Oberlin College and his MD/PhD from New York University in 1972. He did a residency in pathology at Bellevue Hospital. After one year, he joined the US Public Health Service and the National Cancer Institute in 1973, and was hired as staff in 1975. In 1977, he became head of the viral pathology section of the Division of Cancer Cause and Prevention. [4] He relocated to St Jude in 1983, and became an HHMI Investigator in 1988. [3] He has received several awards for his research in cyclin-dependent kinases and their role in cell cycle and cancer growth. [5]

He is married to Martine Roussel, a biologist, and has 3 children. [1]

Awards and honors

Related Research Articles

Arul Chinnaiyan

Arul M. Chinnaiyan is a Hicks Endowed Professor of Pathology and professor of pathology and urology at the University of Michigan Medical School. He is also a Howard Hughes medical Investigator (HHMI) at the Howard Hughes Medical Institute.

Charles Sawyers American physician-scientist (born 1959)

Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.

John Mendelsohn (doctor)

John Mendelsohn was a president of the University of Texas MD Anderson Cancer Center in Houston. He was an internationally recognized leader in cancer research.

Robert D. Schreiber American immunologist

Robert D. Schreiber is an immunologist and currently is the Alumni Endowed Professor of Pathology and Immunology at Washington University School of Medicine. Schreiber has led a major revision in our understanding of how the immune system interacts with cancer. His work on the cancer immunoediting hypothesis has helped reveal that the immune system is not only capable of destroying cancers, but can also drive them into a dormant state that, in some cases, results in an improved state of malignancy.

Joan Massagué

Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.

Arnold Jay Levine, is an American Molecular biologist. He was awarded the 1998 Louisa Gross Horwitz Prize for Biology or Biochemistry and was the first recipient of the Albany Medical Center Prize in Medicine and Biomedical Research in 2001 for his discovery of the tumor suppressor protein p53.

Aviv Regev Bioinformatician

Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.

Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.

James P. Allison American immunologist and Nobel laureate (born 1948)

James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.

Peter Carey Nowell was a cancer researcher and co-discoverer of the Philadelphia chromosome. At the time of his death, he was the Gaylord P. and Mary Louise Harnwell Emeritus Professor of Pathology and Laboratory Medicine at the University of Pennsylvania.

Joan S. Brugge is the Louise Foote Pfeiffer Professor of Cell Biology and the Director of the Ludwig Center at Harvard Medical School, where she also served as the Chair of the Department of Cell Biology from 2004 to 2014. Her research focuses on cancer biology, and she has been recognized for her explorations into the Rous sarcoma virus, extracellular matrix adhesion, and epithelial tumor progression in breast cancer.

William Kaelin Jr.

William G. Kaelin Jr. is an American Nobel Laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana-Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

Carl H. June American immunologist and oncologist

Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research into T cell therapies for the treatment of cancer. In 2020 he was elected to the American Philosophical Society.

Scott W. Lowe American geneticist

Scott William Lowe is Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is recognized for his research on the tumor suppressor gene, p53, which is mutated in nearly half of cancers.

Nikola Panayot Pavletich is the chair of structural biology at Memorial Sloan Kettering Cancer Center.

Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University. She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.

Michael B. Kastan is the executive director of the Duke Cancer Institute and professor of pharmacology and cancer biology.

Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.


Guillermina 'Gigi' Lozano is an American geneticist. She is a professor at University of Texas MD Anderson Cancer Center. Lozano is recognised for her studies of the p53 tumour suppressor pathway, characterising the protein as a regulator of gene expression.

James R. Downing is an American pediatric oncologist and executive. He is the president and chief executive officer of St. Jude Children's Research Hospital.

References

  1. 1 2 "Archived copy" (PDF). Archived from the original (PDF) on 2016-07-28. Retrieved 2016-11-22.{{cite web}}: CS1 maint: archived copy as title (link)
  2. "Charles J. Sherr, MD, PhD". Stjude.org.
  3. 1 2 "Charles J. Sherr, MD, PhD". Hhmi.org.
  4. "Oral History - Charles Sherr". Library.cshl.edu. Retrieved 20 May 2018.
  5. 1 2 [ dead link ]
  6. "Charles J. Sherr, MD, PhD". Aacr.org. Retrieved 20 May 2018.
  7. "Charles J. Sherr to receive Prize for Scientific Excellence in Medicine". News-medical.net. 10 October 2013. Retrieved 20 May 2018.